Evidence map›Paper›PMID 31661029›Full record

ArticleTrials2019

Reducing research waste by promoting informed responses to invitations to participate in clinical trials.

Katie Gillies, Iain Chalmers, Paul Glasziou, Diana Elbourne, Jim Elliott, Shaun Treweek

Abstract readLetter
In one paragraph

Article in Trials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Giving and taking: ethical treatment assignment in controlled trials.Journal of the Royal Society of Medicine · 2021
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katie GilliesHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZB,, UK. k.gillies@abdn.ac.uk.ORCID http://orcid.org/0000-0001-7890-2854
Iain ChalmersCentre for Evidence-Based Medicine, University of Oxford, Oxford, UK.
Paul GlasziouBond University, Robina, QLD, 4226,, Australia.
Diana ElbourneLondon School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HY,, UK.
Jim ElliottHealth Research Authority, Skipton House, London, SE1 6LH,, UK.
Shaun TreweekHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZB,, UK.

Funding

Chief Scientist Office HSRU1Medical Research Council MR/L01193X/1
6 · The paper itself

Abstract

Poor recruitment to, and retention in, clinical trials is a source of research waste that could be reduced by more informed choices about participation. Barriers to effective recruitment and retention can be wide-ranging but relevance of the questions being addressed by trials and the outcomes that they are assessing are key for potential participants. Decisions about trial participation should be informed by general and trial-specific information and by considering broader assessments of 'informedness' and how they impact on both recruitment and retention. We suggest that more informed decisions about trial participation should encourage personally appropriate decisions, increase recruitment and retention, and reduce research waste and increase its value.

Indexed as

Clinical Trials as TopicInformed ConsentPatient ParticipationHumansClinical trialsInformed choiceRecruitmentResearch wasteRetention

Identifiers

PMID31661029
PMCPMC6819580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.